Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency

Erstveröffentlichung

2020

Authors

Werner-Klein, Melanie

Grujovic, Ana

Irlbeck, Christoph

Hoffmann, Martin

Koerkel-Qu, Huiqin

et al.

Wissenschaftlicher Artikel

Published in

Nature Communications ; 11 (2020), 1. - Art.-Nr. 4977. - ISSN 2041-1723

Link to publication

https://dx.doi.org/10.1038/s41467-020-18701-4

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[Free subject headings]: DISSEMINATED TUMOR-CELLS | COMPARATIVE GENOMIC HYBRIDIZATION | METASTATIC BREAST-CANCER | BONE-MARROW | IN-VIVO | EARLY DISSEMINATION | SOLUBLE GP130 | STEM-CELLS | RECEPTOR | IL-6
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record